Cited by 348Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsAdrenal Hormones and Disorders

The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

Open access

Wallach, Edward E., Barbieri, Robert L., Smith, Samuel, Ryan, Kenneth J.·1988·Fertility and Sterility

DOI 10.1016/s0015-0282(16)60060-2

Open this paper in CoChat — free account Open PDF

Abstract

The evidence that supports the hypothesis that insulin and LH both regulate ovarian androgen production was presented. The most dramatic clinical example of the association between hyperinsulinemia and hyperandrogenism is the HAIR-AN syndrome. Our hypothesis is that, in the HAIR-AN syndrome, the severe insulin resistance causes a compensatory hyperinsulinemia, which stimulates ovarian androgen production if adequate LH is present. The acanthosis nigricans is an epiphenomenon of the syndrome. Acanthosis nigricans is a dermatologic manifestation of severe insulin resistance. In vitro evidence suggests that insulin and IGF-I stimulate androgen production in incubations of human stroma and theca. The stromatropic effects of insulin may sensitize the stroma to the stimulatory effects of LH. In some hyperandrogenic-insulin-resistant women, a glucose load appears to produce an acute rise in circulating androgens. The magnitude of the rise in circulating androgens is proportional to the magnitude of the insulin response to the glucose load. These data suggest that hyperinsulinemia may play a central role in the development of ovarian hyperandrogenism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(16)60060-2

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
The Syndromes of Insulin Resistance and Acanthosis Nigricans
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Görden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,101
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,013
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Insulin Stimulates Androgen Accumulation in Incubations of Ovarian Stroma Obtained from Women with Hyperandrogenism*
Barbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R. W., Judd, H. L., Yen, S. S. C., Rakoff, J. S., Vandenberg, G., & Naftolin, F. N. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 618
Relationship of Androgenic Activity to Body Fat Topography, Fat Cell Morphology, and Metabolic Aberrations in Premenopausal Women*
EVANS, D. J., Hoffmann, R. G., Kalkhoff, R. K., & Kissebah, A. H. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-304 · Cited by 582

Show all 108 references

Research works printed but not linked: 5

Futterweit, 1983, A case of bilateral dermoid cysts, insulin resistance and polycystic ovarian disease, Mt Sinai J Med (NY), 50, 251
Freychet, 1984, Resistances a l’insuline, Ann Endocrinol (Paris), 45, 107
Achard, 1921, Le virilisme pilaire et son association a l’insuffisance glycolytique (diabete a femmes de barbe), Bull Acad Natl Med (Paris), 86, 51
Hollingsworth, 1969, Acanthosis nigricans and obesity, Arch Intern Med, 124, 481, 10.1001/archinte.1969.00300200093015 · DOI
Flier, 1985, Acanthosis nigricans in obese women with hyperandrogenism, Diabetes, 34, 101, 10.2337/diab.34.2.101 · DOI

Sorted by citations

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks, R., Lukanova, A., & Kurzer, M. S. (2002) · PubMed · Cited by 1,038
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Symptoms of menopause — global prevalence, physiology and implications
Monteleone, P., Mascagni, G., Giannini, A., Genazzani, A. R., & Simoncini, T. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.180 · Cited by 893
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 852
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 807
Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
Kaaks, R., & Lukanova, A. (2001) · Proceedings of The Nutrition Society · doi:10.1079/pns200070 · Cited by 610
Acne vulgaris: a disease of Western civilization
Cordain, L., Lindeberg, S., Hurtado, M., Hill, K., Eaton, S. B., & Brand-Miller, J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.12.1584 · Cited by 500
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Talbott, E. O., Guzick, D. S., Clerici, A., Berga, S. L., Detre, K. M., Weimer, K., & Kuller, L. H. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 499
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features
Morales, A. J., Laughlin, G. A., Bützow, T. L., Maheshwari, H., Baumann, G., & Yen, S. S. C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768842 · Cited by 453
Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet
Crosignani, P. G. (2003) · Human Reproduction · doi:10.1093/humrep/deg367 · Cited by 359
Nutrition, hormones, and breast cancer: Is insulin the missing link?
Kaaks, R. (1996) · Cancer Causes & Control · doi:10.1007/bf00051703 · Cited by 354
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
Ciaraldi, T. P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.577 · Cited by 336
Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.
Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371
Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
M, E., Acosta, A., & Mendoza, S. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00296-2 · Cited by 305
Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 306
On the Paradox of Insulin-Induced Hyperandrogenism in Insulin-Resistant States
Poretsky, L. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-3 · Cited by 258
Metformin directly inhibits androgen production in human thecal cells
Attia, G. R., Rainey, W. E., & Carr, B. R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01975-6 · Cited by 256
Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin
Bergh, C., Carlsson, B., Olsson, J., Selleskog, U., & Hillensjø, T. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55675-1 · Cited by 253
Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women
Guzick, D. S., Wing, R., Smith, D., Berga, S. L., & Winters, S. J. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56632-1 · Cited by 246
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment
Stener‐Victorin, E., & Deng, Q. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00517-x · Cited by 227
Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
Guzick, D. S., Talbott, E. O., Sutton-Tyrrell, K., Herzog, H. C., Kuller, L. H., & Wolfson, S. K. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70665-8 · Cited by 210
Hyperinsulinemic diseases of civilization: more than just Syndrome X
Cordain, L., Eades, M. R., & Eades, M. D. (2003) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(03)00011-4 · Cited by 211
“Both insulin and IGF-1 stimulate the synthesis of androgens in ovarian (Barbieri et al., 1988; Cara, 1994) and testicular (De Mellow et al.”
Background
The Follicle-Deplete Mouse Ovary Produces Androgen1
Mayer, L. P., Devine, P. J., Dyer, C. A., & Hoyer, P. B. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.016113 · Cited by 209
Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system
Hunter, S. J., & Garvey, W. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00300-3 · Cited by 200
Polycystic ovary syndrome and environmental toxins
Rutkowska, A. Z., & Diamanti‐Kandarakis, E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.031 · Cited by 199
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women
Holte, J., Bergh, T., Gennarelli, G., & WIDE, L. E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02578.x · Cited by 173
Can metformin reduce insulin resistance in polycystic ovary syndrome?
Açbay, Ö., & Gündoğdu, S. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58266-1 · Cited by 173
Menopause in Type 1 Diabetic Women
Dorman, J. S., Steenkiste, A. R., Foley, T. P., Strotmeyer, E. S., Burke, J. P., Kuller, L. H., & Kwoh, C. K. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1857 · Cited by 171
Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary.
Hernández, E. R., Hurwitz, A., VERA, A., Pellicer, A., Adashi, E. Y., LeRoith, D., & Roberts, C. T. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.2.1309838 · Cited by 160
The Effects of Insulin and Insulin-Like Growth Factors-I and -II on Estradiol Production by Granulosa Cells of Polycystic Ovaries*
Erickson, G. F., Magoffin, D. A., Cragun, J. R., & Chang, R. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-894 · Cited by 157
High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus
Holte, J., Gennarelli, G., WIDE, L. E., Lithell, H., & Berne, C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4707 · Cited by 149
Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study
Preziosi, P., Barrett-Connor, E. L., Papoz, L., Roger, M., Saint-Paul, M., NAHOUL, K., & Simon, D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432770 · Cited by 145
Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women
Tulppala, M., Stenman, U., Cacciatore, B., & Ylikorkala, O. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb12978.x · Cited by 144
Implications for the Role of Diet in Acne
Cordain, L. (2005) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2005.04.002 · Cited by 140
Diabetes and endometrial cancer in the Iowa women's health study.
Anderson, K. E., Anderson, E. L., Mink, P. J., Hong, C. P., Kushi, L. H., Sellers, T. A., Lazovich, D., & Folsom, A. R. (2001) · PubMed · Cited by 139
Advanced glycation end products and their relevance in female reproduction
Merhi, Z. O. (2013) · Human Reproduction · doi:10.1093/humrep/det383 · Cited by 137
“Both insulin-like growth factor-1 (IGF-1) and insulin are potent stimulators of ovarian androgen production, an action likely mediated via the insulin receptor (Burghen et al., 1980; Barbieri et al., 1988).”
Background
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 137
Juvenile acanthosis nigricans
Sinha, S., & Schwartz, R. A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.016 · Cited by 134
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
Nestler, J. E., & Strauss, J. F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30245-7 · Cited by 132
Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
Norman, R. J., Masters, S. C., & Hague, W. M. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58687-7 · Cited by 132
Effects of Rosiglitazone in Obese Women with Polycystic Ovary Syndrome and Severe Insulin Resistance
Sepilian, V., & Nagamani, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1376 · Cited by 130
Randomized Placebo-Controlled Trial of Metformin for Adolescents With Polycystic Ovary Syndrome
Bridger, T., MacDonald, S., Baltzer, F., & Rodd, C. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.3.241 · Cited by 126
“Although the pathogenesis is not fully understood, evidence suggests insulin resistance and hyperinsulinemia play a key pathophysiologic role by promoting excess androgen production from both the ovaries and adrenal glands.(10,11) Many studies have demonstrated improvement of hyperinsulinemia, hyperandrogenemia, and c…”
Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study
Jivraj, S., Anstie, B., Cheong, Y. C., Fairlie, F., Laird, S. M., & Li, T. C. (2001) · Human Reproduction · doi:10.1093/humrep/16.1.102 · Cited by 126
Hormonal treatment of acne vulgaris: an update
Elsaie, M. L. (2016) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s114830 · Cited by 122
“Insulin has a direct stimulant effect on androgenesis besides inhibiting the SHBG synthesis by the liver.(26) Of interest, 50% of cases with ovarian hyperandrogenism experience an existing functional adrenal hyperandrogenism.”
The Impact of Insulin Secretion on the Ovarian Response to Exogenous Gonadotropins in Polycystic Ovary Syndrome
Fulghesu, A. M., Villa, P., Pavone, V., Guido, M., Apa, R., Caruso, A., Lanzone, A., Rossodivita, A., & Mancuso, S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3727 · Cited by 128
A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
Shele, G., Genkil, J., & Speelman, D. L. (2020) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk5020035 · Cited by 135
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
Lowenstein, E. J. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2006.00077.x · Cited by 111
“The hyperandrogenism, insulin resistance and AN syndrome (HAIR-AN) is considered a severe variant or subphenotype of PCOS, often with genetic and familial predisposition (53).”
Background
The Relation of Type 2 Diabetes and Cancer
Strickler, H. D., Wylie‐Rosett, J., Rohan, T. E., Hoover, D. R., Smoller, S., Burk, R. D., & Yu, H. (2001) · Diabetes Technology & Therapeutics · doi:10.1089/152091501300209633 · Cited by 114
Clinical Manifestations and Treatment of Dysfunctional Uterine Bleeding
Bayer, S. R. (1993) · JAMA · doi:10.1001/jama.1993.03500140075039 · Cited by 113
Dietary glycemic index and glucose, insulin, insulin-like growth factor-I, insulin-like growth factor binding protein 3, and leptin levels in patients with acne
Kaymak, Y., Adisen, E., Ilter, N., Bideci, A., Gurler, D., & Celik, B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.028 · Cited by 113
Direct Thiazolidinedione Action in the Human Ovary: Insulin-Independent and Insulin-Sensitizing Effects on Steroidogenesis and Insulin-Like Growth Factor Binding Protein-1 Production
Seto‐Young, D., Paliou, M., Schlosser, J., Avtanski, D. B., Park, A., Patel, P., Holcomb, K., Chang, P., & Poretsky, L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0469 · Cited by 107
Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies.
Kronfeld, D., Treiber, K., & Geor, R. (2005) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2005.226.712 · Cited by 109
Menstrual Irregularity in Women with Acromegaly
Kaltsas, G., Mukherjee, J. J., Jenkins, P. J., Satta, M. A., Islam, N., Monson, J. P., BESSER, G. M., & Grossman, A. B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5858 · Cited by 108
“Acromegaly induces hyperinsulinemia and an insulin-resistant state (21), and excessive GH levels can increase androgen secretion (13, 22, 23), whereas the severity of the clinical expression of PCOS is affected by both the degree of hyperandrogenism and insulin resistance (24).”
Background
Adipose tissue expandability and the early origins of PCOS
de Zegher, F., López‐Bermejo, A., & Ibáñez, L. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.06.003 · Cited by 108
Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance)
Laron, Z., & Klinger, B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380176 · Cited by 107
Hormone Profiles in Young Adults with Epilepsy Treated with Sodium Valproate or Lamotrigine Monotherapy
Stephen, L. J., Kwan, P., Shapiro, D., Dominiczak, M. H., & Brodie, M. J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.0420081002.x · Cited by 106
“Affected women can also have an elevated serum luteinising hormone (LH)/ follicle-stimulating hormone (FSH) ratio, but this is a less sensitive marker (12,15).”
Background
Ovarian stromal hypertrophy in hyperandrogenic women
Dewailly, D., Robert, Y., Helln, I., Ardaens, Y., Thomas‐Desrousseaux, P., Lemaltre, L., & Fossati, P. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb01818.x · Cited by 107
“Insulin resistance with its compensatory hyperinsulinism is a common finding in women with PCOS (Barbieri et al., 1988).”
Background
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K., Mastorakos, G. P., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 112
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome
Ünlühızarcı, K., Keleştimur, F., Bayram, F., Şahin, Y., & Tutuş, A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00786.x · Cited by 104
“…to obesity (Changet al., 1983; Barbieriet al.,1988; Nestleret al.,1989a) and appears to play a key pathogenetic role in the ovarian androgen overproduction (Barbieri et al., 1988; Willis et al., 1996) and glucose intolerance in PCOS (Ciaraldiet al., 1992; Ehrmannet al., 1995; Dunaifet al., 1996).”
Background
The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome
Nestler, J. E., Clore, J. N., & Blackard, W. G. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90640-6 · Cited by 103
Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome
Norman, R. J., Mahabeer, S., & Masters, S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57297-5 · Cited by 102
The Effect of a Desogestrel-Containing Oral Contraceptive on Glucose Tolerance and Leptin Concentrations in Hyperandrogenic Women
Nader, S., Riad, M. G., & Saad, M. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4192 · Cited by 100
A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial
Smith, R., Mann, N., Mäkeläinen, H., Roper, J., Braue, A., & Varigos, G. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700307 · Cited by 98
Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea
Pirwany, I. R., Yates, R. W. S., Cameron, I., & Fleming, R. (1999) · Human Reproduction · doi:10.1093/humrep/14.12.2963 · Cited by 100
Genetics of polycystic ovary syndrome
Mykhalchenko, K., Lizneva, D., Trofimova, T., Walker, W., Сутурина, Л. В., Diamond, M. P., & Azziz, R. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1340833 · Cited by 128
“Because the ovarian stroma (such as theca and interstitial cells) secrete androgens in response to stimulation with higher insulin levels and because most PCOS subjects are insulin resistant, the INSR has been a natural candidate gene target [17,18].”
Background
Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats
Poretsky, L., Clemons, J. L., & Bogovich, K. (1992) · Metabolism · doi:10.1016/0026-0495(92)90175-a · Cited by 97
Female Gonadal Function before and after Treatment of Acromegaly
Grynberg, M., Salenave, S., Young, J., & Chanson, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2815 · Cited by 96
MENSTRUAL DISORDERS IN ADOLESCENTS
Gordon, C. M. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70135-8 · Cited by 92
Higher risk of preeclampsia in the polycystic ovary syndrome
de Vries, M. J., Dekker, G., & Schoemaker, J. (1998) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(97)00164-4 · Cited by 92
Insulin resistance, insulin‐like growth factor I and breast cancer: A hypothesis
Kazer, R. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620408 · Cited by 92
Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women
Hollmann, M., Runnebaum, B., & Gerhard, I. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800433 · Cited by 90
Metabolic approaches to the subclassification of polycystic ovary syndrome
Norman, R. J., Masters, S. C., Hague, W. M., Beng, C., Pannall, P. R., & Wang, J. X. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57364-6 · Cited by 90
Metformin for the Treatment of Polycystic Ovary Syndrome
Barbieri, R. L. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00045-0 · Cited by 95
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance
Morrow, L., O'Brien, M. B., Moller, D. E., Flier, J. S., & Moses, A. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027228 · Cited by 88
Identification of a Functional Polymorphism of the Human Type 5 17β-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome
Qin, K., Ehrmann, D. A., Cox, N. J., Refetoff, S., & Rosenfield, R. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2012 · Cited by 84
NON–INSULIN-DEPENDENT DIABETES MELLITUS IN CHILDHOOD AND ADOLESCENCE
Glaser, N. S. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70479-x · Cited by 84
Development of hyperandrogenism during treatment with insulin‐like growth factor‐I (IGF‐I) in female patients with Laron syndrome
Klinger, V., Anin, Silbergeld, Eshet, & Laron (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00356.x · Cited by 85
“The pathophysiology of this syndrome is not fully understood (Jacobs, 1996) and insulin resistance and resulting hyperinsulinaemia have been implicated in its pathogenesis (Barbieri et al., 1988; Willis et al., 1996).”
Background
Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate
Luef, G. J., Abraham, I., Trinka, E., Alge, A., Windisch, J., Daxenbichler, G., Unterberger, I., Seppi, K., Lechleitner, M., Krämer, G., et al. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(01)00317-5 · Cited by 84
Acne, Hirsutism, and Alopecia in Adolescent Girls: Clinical Expressions of Androgen Excess
Rosenfield, R. L., & Lucky, A. W. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30148-8 · Cited by 82
A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate–resistant polycystic ovary syndrome
Rouzi, A. A., & Ardawi, M. S. M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1312 · Cited by 82
Relationship of upper body obesity to menstrual disorders
Douchi, T., Kuwahata, R., Yamamoto, S., Oki, T., Yamasaki, H., & Nagata, Y. (2002) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810210.x · Cited by 80
Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial
George, S. S. (2003) · Human Reproduction · doi:10.1093/humrep/deg105 · Cited by 79
Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
Rosenfield, R. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117430 · Cited by 77
Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease
Anttila, L., Ding, Y., Ruutiainen, K., Erkkola, R., Irjala, K. M. A., & Huhtaniemi, I. T. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54352-0 · Cited by 74
Effect of Acute Physiological Elevations of Insulin on Circulating Androgen Levels in Nonobese Women*
Diamond, M. P., GRAINGER, D. A., LAUDANO, A. J., Starick-Zych, K., & DeFronzo, R. A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-883 · Cited by 74
Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome
Grulet, H., Hécart, A. C., Delemer, B., Gross, A., Sulmont, V., Leuténegger, M., & Caron, J. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02144.x · Cited by 73
Should patients with polycystic ovary syndrome be treated with metformin?: Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction
Stadtmauer, L. A. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3016 · Cited by 73
Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature
Thomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00758.x · Cited by 70
“IR and compensatory hyperinsulinemia act on ovarian tissue, disturbing ovarian hormone regulation and the menstrual cycle, resulting in infertility (5,23,24) and contribute directly to hyperandrogenemia by stimulating thecal cell androgen production (2,25,26).”
Background
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
Slowinska-Srzednicka, J., Zgliczyński, S., Wierzbicki, M., Srzednicki, M., Stopińska-Głuszak, U., Zgliczyński, W., Soszynski, P. A., Chotkowska, E., Bednarska, M., & Sadowski, Z. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346870 · Cited by 70
Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly
Kaltsas, G., Androulakis, I. I., Tziveriotis, K., Papadogias, D., Tsikkini, A., Makras, P., Dimitriou, K., Stathopoulou, A., & Piaditis, G. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02987.x · Cited by 69
The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad098 · Cited by 72
Upper Body Obesity and Hyperinsulinemia Are Associated with Anovulation
Morán, C., Hernández, E., Ruíz, J. E., Fonseca, M. E., BERMUDEZ, J. A., & Zárate, A. (1999) · Gynecologic and Obstetric Investigation · doi:10.1159/000010052 · Cited by 66
Enhanced Thecal Androgen Production Is Prenatally Programmed in an Ovine Model of Polycystic Ovary Syndrome
Hogg, K., Young, J. M., Oliver, E. M., de Souza, C. J. H., McNeilly, A. S., & Duncan, W. C. (2011) · Endocrinology · doi:10.1210/en.2011-1607 · Cited by 64
Ovarian morphology and insulin sensitivity in women with bulimia nervosa
Raphael, F. J., Rodin, D. A., Peattle, A., Bano, G., Kent, A. S. H., Nussey, S., & Lacey, J. H. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02617.x · Cited by 61
“85) have moderate to severe insulin resistance and chronic hyperinsulinaemia and this may cause an increase in ovarian androgen production (Barbieri et al., 1988).”
Background
Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women
Sakumoto, T., Tokunaga, Y., Tanaka, H., Nohara, M., 茂木, 絵., Shinkawa, T., Nakaza, A., & Higashi, M. (2010) · Reproductive Medicine and Biology · doi:10.1007/s12522-010-0062-5 · Cited by 60
“Insulin, by acting via its receptor, appears to promote ovarian and adrenal androgen biosynthesis [35, 36], amplifying luteinizing hormone (LH)-induced androgen production by theca cells and resulting in hyperandrogenemia [37, 38].”
Background
Ferredoxin 1 regulates granulosa cell apoptosis and autophagy in polycystic ovary syndrome
Xing, J., Qiao, G., Luo, X., Liu, S., Chen, S., Ye, G., Zhang, C., & Yi, J. (2023) · Clinical Science · doi:10.1042/cs20220408 · Cited by 59
Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States
Potischman, N. A., Coates, R. J., Swanson, C. A., Carroll, R. J., Daling, J. R., BROGAN, D. R., Gammon, M. D., Midthune, D., Curtin, J., & Brinton, L. A. (2002) · Cancer Causes & Control · doi:10.1023/a:1021919416101 · Cited by 57
“Further, insulin resistance can lead to elevated androgen and estrogen concentrations because insulin stimulates ovarian steroid secretion [33, 37, 38].”
Background
Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
Liepa, G. U., Sengupta, A. M., & Karsies, D. (2008) · Nutrition in Clinical Practice · doi:10.1177/011542650802300163 · Cited by 58
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56

Authors: Wallach, E. E., Barbieri, R. L., Smith, S., & Ryan, K. J.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Barbieri, Robert L.
Ryan, Kenneth J.
Venue: Fertility and Sterility
Publisher: Elsevier BV
Published: 1988-08
Volume: 50
Issue: 2
Pages: 197-212
ISSN: 0015-0282 (ISSN-L)
DOI: 10.1016/s0015-0282(16)60060-2
OpenAlex: W194639418
Cited by: 348
References: 108
Citations by year: 2026: 4 · 2025: 6 · 2024: 3 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 2
FWCI: 10.95
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 12352 d)
Locations: Fertility and Sterility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: hyperinsulinemia, ovarian hyperandrogenism, polycystic ovary syndrome, androgen overproduction, PCOS pathogenesis, insulin resistance, hypothalamic-pituitary-ovarian axis, adrenal androgen production
MeSH terms: Acanthosis Nigricans, Androgens, Female, Humans, Hyperinsulinism, Insulin Resistance, Ovary, Polycystic Ovary Syndrome, Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks